<DOC>
	<DOCNO>NCT00522587</DOCNO>
	<brief_summary>During study , pharmacodynamic interaction sevoflurane remifentanil study .</brief_summary>
	<brief_title>Sevoflurane-Remifentanil Interaction : Multiple Response Surfaces , Validation Calibration Stimuli , Validation Intraoperative Isobole Concept Investigating Remifentanil Induced Opioid Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>American Society Anesthesia class I II patient Aged 1860 year Scheduled surgery general anesthesia Weight le 70 % 130 % ideal body weight Neurological disorder Diseases involve cardiovascular system ( hypertension , coronary artery disease , prior acute myocardial infarction ( AMI ) , valvular and/or muscular disease involve decrease ejection fraction , arrhythmia , either symptomatic require continuous medication/pacemaker/automatic implantable cardioverter defibrillator [ AICD ] ) Pulmonary disease include asthma , severe chronic obstructive pulmonary disease ( COPD ) , etc . Gastric diseases include reflux , endocrinological disease Recent use psychoactive medication , include alcohol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>